• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TOSOH CORPORATION TOSOH HLC-723G8 ANALYZER G8

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TOSOH CORPORATION TOSOH HLC-723G8 ANALYZER G8 Back to Search Results
Model Number G8
Device Problems Use of Device Problem (1670); Filtration Problem (2941)
Patient Problem No Information (3190)
Event Type  malfunction  
Manufacturer Narrative
This report is being refiled per fda request to indicate initial report type.This report is an "initial" to uf/importer report #: 3005529799-2015-00009.Contact office: (b)(4).Manufacturer name/address: (b)(4).Date received by manufacturer: 20-jul-2015.510k: k071132.Adverse event: follow-up # 1.Type of event: malfunction follow up: correction, additional information.Adverse event codes: (b)(4).Device usage: reuse.Additional information: the most probable cause of the abnormal peaks is related to the extended column life beyond 2500 injections.Review of the g8 variant analysis mode training manual informs the user of the following: columns are warranted for 2500 injections.After column replacement, use the column reset key to reset the column count.Flag 06 may be programmed to alert the operator after 2500 injections are performed with a specific column.When the flag for number of injections is programmed, every specimen that exceeds the limit will be printed with the flag.Tosoh bioscience, inc.Is submitting on behalf of the foreign manufacturer, tosoh corporation, per exemption number e2017013.This report is being submitted due to a retrospective review conducted under capa(b)(4).
 
Event Description
On 20jul-2015, tosoh bioscience, inc.Was notified of erroneous patient hba1c results that were reported on 25-jun-2015.The testing was done on a tosoh hplc g8 analyzer, and all quality controls were within acceptable target ranges.Chromatograms were reviewed after the results were reported and it was discovered that the chromatogram peaks looked abnormal and test results should not have been reported.The column count at the time of this event was 3800, and required replacement.Following replacement of the column, calibration was performed and quality controls run.Quality controls were within acceptable range (level 1 result: 6.3, acceptable range: 5.66 - 6.86; level 2 result: 9.4, acceptable range: 8.37 - 9.94), and the chromatogram peaks looked normal.Of the 200 patient results reviewed with abnormal looking chromatograms, approximately 43 specimens in the range of 7.0- to 7.9 were repeated following installation of the new column.The repeated specimen results were lower, and corrected patient results were reported to the ordering physicians.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TOSOH HLC-723G8 ANALYZER G8
Type of Device
G8
Manufacturer (Section D)
TOSOH CORPORATION
shiba-koen first building
3-8-2 shiba
minato-ku, tokyo, japan 10586 23
JA  1058623
MDR Report Key7435119
MDR Text Key261265310
Report Number3005529799-2015-00009
Device Sequence Number1
Product Code LCP
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 04/16/2018,02/03/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/16/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberG8
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA04/16/2018
Event Location Outpatient Diagnostic Facility
Date Report to Manufacturer04/16/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
QUALITY CONTROL MAS 1606
-
-